1. Home
  2. PCSA vs ILAG Comparison

PCSA vs ILAG Comparison

Compare PCSA & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

HOLD

Current Price

$3.56

Market Cap

8.0M

Sector

Health Care

ML Signal

HOLD

Logo Intelligent Living Application Group Inc.

ILAG

Intelligent Living Application Group Inc.

HOLD

Current Price

$3.60

Market Cap

8.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCSA
ILAG
Founded
2011
1981
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.0M
8.1M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
PCSA
ILAG
Price
$3.56
$3.60
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
321.0K
36.5K
Earning Date
11-06-2025
12-22-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,338,785.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.74
$2.74
52 Week High
$22.80
$9.80

Technical Indicators

Market Signals
Indicator
PCSA
ILAG
Relative Strength Index (RSI) 59.91 67.87
Support Level $3.07 $3.22
Resistance Level $3.80 $4.55
Average True Range (ATR) 0.31 0.39
MACD -0.08 -0.01
Stochastic Oscillator 67.27 68.18

Price Performance

Historical Comparison
PCSA
ILAG

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.

Share on Social Networks: